Combinatorial mapping of E3 ubiquitin ligases to their target substrates

E3 ubiquitin ligases (E3s) confer specificity of protein degradation through ubiquitination of substrate proteins. Yet, the vast majority of the >600 human E3s have no known substrates. To identify proteolytic E3-substrate pairs at scale, we developed combinatorial mapping of E3 targets (COMET), a framework for testing the role of many E3s in degrading many candidate substrates within a single experiment. We applied COMET to SCF ubiquitin ligase subunits that mediate degradation of target substrates (6,716 F-box-ORF [open reading frame] combinations) and E3s that degrade short-lived transcription factors (TFs) (26,028 E3-TF combinations). Our data suggest that many E3-substrate relationships are complex rather than 1:1 associations. Finally, we leverage deep learning to predict the structural basis of E3-substrate interactions and probe the strengths and limits of such models. Looking forward, we consider the practicality of transposing this framework, i.e., computational structural prediction of all possible E3-substrate interactions, followed by multiplex experimental validation.

Authors

Institutions

Publication Details

Journal
Molecular Cell
Published
2025-02-01
DOI
https://doi.org/10.1016/j.molcel.2025.01.016
Citations
16
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
12.90

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combinatorial mapping of E3 ubiquitin ligases to their target substrates

Shruti Jain, Cole Trapnell, Riza M. Daza, Chase C. Suiter et al.
16 citations
Molecular Cell
Ubiquitin and proteasome pathways
12.90
article

Combinatorial mapping of E3 ubiquitin ligases to their target substrates

Shruti Jain, Cole Trapnell, Riza M. Daza, Chase C. Suiter, Florence M. Chardon, Diego Calderon, Ning Zheng, Jay Shendure, Choli Lee, David Lee, M. Isabel Chiu
article en
16 citations

Abstract

E3 ubiquitin ligases (E3s) confer specificity of protein degradation through ubiquitination of substrate proteins. Yet, the vast majority of the >600 human E3s have no known substrates. To identify proteolytic E3-substrate pairs at scale, we developed combinatorial mapping of E3 targets (COMET), a framework for testing the role of many E3s in degrading many candidate substrates within a single experiment. We applied COMET to SCF ubiquitin ligase subunits that mediate degradation of target substrates (6,716 F-box-ORF [open reading frame] combinations) and E3s that degrade short-lived transcription factors (TFs) (26,028 E3-TF combinations). Our data suggest that many E3-substrate relationships are complex rather than 1:1 associations. Finally, we leverage deep learning to predict the structural basis of E3-substrate interactions and probe the strengths and limits of such models. Looking forward, we consider the practicality of transposing this framework, i.e., computational structural prediction of all possible E3-substrate interactions, followed by multiplex experimental validation.

Molecular CellVol. 85(4)
Howard Hughes Medical Institute (US), University of Washington (US), Brotman Baty Institute (US), Seattle University (US)
Howard Hughes Medical Institute, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Institute of General Medical Sciences
Zero hunger
Openalex Percentile: Top 1%
Ubiquitin and proteasome pathways
12.90
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.